Clinical Trials Logo

Clinical Trial Summary

To evaluate the safety and efficacy of ixekizumab in lichen planus and lichen planopilaris clinical response by Total Body Surface (TBS) determination, Investigator Global Assessment (IGA) Score, Lichen Planopilaris Activity Index (LPPAI), and Frontal Fibrosing Alopecia Severity Score (FFASS).

Clinical Trial Description

A proof of concept, non-randomized, one center study to explore the safety and efficacy of 16 weeks of treatment with ixekizumab in adult patients with lichen planus. The total study period will consist of 24 weeks including a 2 week screening/washout, 16 weeks of active therapy and 8 weeks of follow up. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05030415
Study type Interventional
Source University of New Mexico
Contact John R Durkin, MD MBA
Phone 5052726222
Email [email protected]
Status Recruiting
Phase Early Phase 1
Start date August 31, 2021
Completion date August 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03340155 - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases N/A
Completed NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections Phase 4
Recruiting NCT04697563 - Laser Therapy in Women With Lichenoid Disorders N/A
Completed NCT03265093 - Use of Injectable Platelet Rich Fibrin in Lichen Planus N/A
Completed NCT03858634 - A Study to Assess the Efficacy, Safety and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases Phase 2
Active, not recruiting NCT02761122 - Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen) N/A
Active, not recruiting NCT00691106 - A Multi-center Study to Evaluate the Safety of Etanercept in the Treatment of Lichen Planus Phase 2
Recruiting NCT02261662 - Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection N/A
Not yet recruiting NCT04892381 - Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
Recruiting NCT02532166 - Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus N/A
Enrolling by invitation NCT03796806 - Methods Validation Assessment for Study of Inflammatory Skin Disease
Completed NCT02850601 - Dexamethasone Solution for the Treatment of Oral Lichen Planus Phase 2
Not yet recruiting NCT01041625 - Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus Phase 2
Completed NCT00824889 - Exploratory Study of Natural Killer Cells in Human Skin N/A
Completed NCT02732145 - Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis N/A
Completed NCT03697460 - Topical Ruxolitinib Lichen Planus Phase 2
Active, not recruiting NCT00341497 - Biomarkers for Oral Cancer
Active, not recruiting NCT00542373 - Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer N/A
Not yet recruiting NCT04952961 - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study N/A
Terminated NCT00285779 - Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus Phase 2